trending Market Intelligence /marketintelligence/en/news-insights/trending/byGzUbSIn4fIczC8r9NYyA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Kitov buys additional stake in TyrNovo

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Kitov buys additional stake in TyrNovo

Kitov Pharmaceuticals Holdings Ltd. acquired an additional 27% stake in TyrNovo Ltd. from unaffiliated minority shareholders for $7 million.

In exchange for the additional stake, Kitov will issue 13,169,689 new shares, or 658,484 American depositary shares, to the group of TyrNovo shareholders.

As a result of the transaction, Kitov now holds about 92% of TyrNovo's issued and outstanding shares. The company previously owned about 65% of TyrNovo.

TyrNovo is an Israel-based developer of novel small molecules in the oncology therapeutic field.